We are driven to advance care by delivering breakthrough cancer therapies to patients who need them.
Our mission is to make exceptional, innovative biopharmaceuticals to improve the lives of patients suffering from serious diseases. Our focus is on cancer. Innovative technologies and smart development strategies are central to our approach.Learn About Our Mission
Learn more about MorphoSys' agreement to acquire Constellation Pharmaceuticals and our strategic funding partnership with Royalty Pharma View Details Here >